Focus: DNA Worldwide is a UK-based biotechnology company specializing in DNA testing, founded in 1999 and focused on psychiatry, gastroenterology, and neurology applications. The company operates as a niche player in the genetic testing segment with limited public disclosure of scale.
Profile data last refreshed 50m ago · AI intelligence enriched 2w ago
DNA Worldwide presents a speculative career opportunity suited only to professionals with strong risk tolerance and genuine interest in early-stage genetic testing; the severe scarcity of hiring and public information makes traditional career planning difficult.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for DNA Worldwide
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from DNA Worldwide's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo